Clinical Trials
16 trialsNCT07572760 2026-05-07
Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.
University of Alicante
Phase NA Recruiting
NCT05297734 2026-04-30
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Phase NA Recruiting
NCT02735252 2025-11-12
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer
University of California, San Francisco
Phase NA Active not recruiting
NCT03344757 2025-09-11
Health Gatherings - For Your Health After Cancer
University of Miami
Phase NA Completed
NCT06835426 2025-02-19
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Algemeen Ziekenhuis Maria Middelares
Phase NA Recruiting
NCT01540994 2025-01-16
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Sharp HealthCare
Phase NA Completed
NCT04811846 2024-12-09
CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood
University Teaching Hospital Hall in Tirol
Phase NA Active not recruiting
NCT04880681 2023-05-01
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Region Skane
Phase NA Unknown
NCT04831307 2021-12-03
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
British Columbia Cancer Agency
Phase NA Unknown
NCT02319239 2020-10-28
ESKO
Tampere University Hospital
Phase NA Completed
NCT04462926 2020-09-17
PSMA-PROSTAPET
Azienda Ospedaliero-Universitaria di Modena
Phase NA Unknown
NCT03887091 2019-06-07
Personal Web Page In Clinical Trial Participant Education
Dana-Farber Cancer Institute
Phase NA Completed
NCT02026960 2018-12-20
RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
Duke University
Phase NA Terminated
NCT01918605 2017-10-27
Protection of Rectum From High Radiation Doses Using a Spacer
University of Oulu
Phase NA Terminated
NCT01799499 2015-09-01
NMIBC TURBT HG
UroGen Pharma Ltd.
Phase NA Withdrawn
NCT00147238 2012-08-07
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
M.D. Anderson Cancer Center
Phase NA Terminated